University of Illinois Chicago researchers are the first to report on the financial conflicts of interest that exist among doctors who review the chest X-rays of coal miners who file workers’ compensation claims of totally disabling disease with the U.S. Department of Labor’s Federal Black Lung Program.
A new study published online in the Annals of the American Thoracic Society examines if the source of physician payment for a medical opinion influences whether the physician finds that a coal miner has black lung disease. The study is the first to look at this relationship in the workers’ compensation process.
تكتسب المعركة العالمية ضد داء السل بعض الأدوات القوية. الطب الدقيق — المُستخدم بالفعل لتخصيص تشخيص الأمراض غير المعدية وعلاجها، مثل: السرطان — وتقنيات الرعاية الصحية، مثل: الطب عن بُعد، لديهما القدرة على تطوير الوقاية والعلاج من داء السل، كما يقول زلالم تمسجين، دكتور الطب، خبير الأمراض المعدية والمدير الطبي لمركز داء السل التابع لمايو كلينك.
Findings should empower the search for better treatments for lung diseases
In support of World TB Day, March 24, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, joins the World Health Organization campaign urging governments to act on the commitments made to end TB.
A luta global contra a tuberculose está ganhando algumas ferramentas poderosas. A medicina de precisão — já usada para personalizar o diagnóstico e o tratamento de doenças não transmissíveis, como o câncer — e as tecnologias de saúde, como a telemedicina, têm potencial para avançar na prevenção e no tratamento da tuberculose, afirma Zelalem Temesgen, M.D.
全球抗击肺结核的努力获得了医疗技术的强大助力。精准医学已经用于非传染性疾病（例如癌症）的诊断和治疗，它和远程医学等医疗技术有可能促进结核病的预防和治疗，妙佑医疗国际 (Mayo Clinic) 肺结核中心的传染病专家和医学主任 Zelalem Temesgen 医学博士 说。
IU study finds COVID-19 differs from other coronaviruses which may be contributing to difficulty in controlling disease spread and burden.
In Biomicrofluidics, researchers review lung-on-chip technologies that represent the vital properties of lung tissue and are capable of recapitulating the fundamental aspects of various pathologies. The researchers reviewed various lung-on-chips and their applications in examining, diagnosing, and treating human viruses, including the coronavirus that causes COVID-19. The knowledge accumulated paves the way to use these models to study the interaction of several human respiratory viruses with the airway epithelium and alveolus in an organ-relevant setting.
New research finds that quitting smoking is an effective way to resolve impaired lung function and airway inflammation associated with waterpipe smoking. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
Most delays ranged between 10 and 45 days, with a median of 24 days, after a visit to a doctor, which exceeds current World Health Organization recommendations of diagnosing and treating TB within two to three weeks of symptom onset Delays were linked to greater risk for disease complications, transmission of infection to household members Older individuals and those with compromised immunity were at greater risk for delayed diagnoses Use of diagnostic molecular testing, use of chest imaging and being seen by a specialist were all linked to more prompt identification of TB infection, suggesting delays may be preventable Findings underscore the need to increase awareness of TB among frontline clinicians who may not suspect TB due to rarity of infection in this country
La lucha mundial contra la tuberculosis ahora cuenta con algunos instrumentos poderosos. La medicina de precisión que ya se aplica para personalizar el diagnóstico y el tratamiento de enfermedades no contagiosas, como el cáncer, junto a las tecnologías para la atención de la salud, como la telemedicina, tienen la capacidad de avanzar la prevención y el tratamiento de la tuberculosis, dice el Dr. Zelalem Temesgen, experto en enfermedades infecciosas y director médico del Centro para Tuberculosis en Mayo Clinic.
The global fight against tuberculosis is gaining some powerful tools. Precision medicine — already used to personalize diagnosis and treatment of noncommunicable diseases such as cancer — and health care technologies such as telemedicine have the potential to advance the prevention and treatment of tuberculosis, says Zelalem Temesgen, M.D., an infectious diseases expert and medical director of the Mayo Clinic Center for Tuberculosis.
New York City's Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for March 2021.
The team at Beth Israel Deaconess Medical Center demonstrated that COVID-19 cases resulted in significantly more weekly hospitalizations, more use of mechanical ventilation and higher mortality rates than influenza.
Topics surrounding asthma and power plant closures, illicit drug use and harm reduction, testing access for homeless, and varied support for pandemic measures will be highlighted in the May 2021 Issue of AJPH.
STS—in collaboration with the GO2 Foundation for Lung Cancer and the American College of Radiology—formally requested that CMS update its coverage policies to reflect the new USPSTF lung cancer screening guidelines.
Hertz Fellow David Schaffer uses high throughput genetic sequencing technology to identify gene variants that can potentially help restore sight, repair hearts damaged by Fabry disease, and improve lung function in patients with cystic fibrosis.
George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today in Anesthesia & Analgesia.
This is a landmark study in so far as being the first to raise the alarm that, despite early successes with Covid-19 vaccines, further research is warranted on a next generation of Covid-19 vaccines.
Register today to cover the ATS 2021 International Conference and explore the ATS 2021 program before the May 14 online event launches.
Seven years ago, Nikki Burleigh of Rahway, New Jersey, was diagnosed with lung cancer and underwent conventional radiation therapy and a lobectomy to remove the affected part of her lung. Her treatment was successful, and she received regular checkups with her pulmonologist and oncologist for several years. But in December 2019, a routine CT scan revealed that Nikki’s lung cancer returned.
Researchers have determined what happens at a cellular level as the lung alveolus forms and allows newborns to breathe air. Understanding this process gives researchers a better sense of how to develop therapies and potentially regenerate this critical tissue in the event of injury.
The science behind the COVID-19 vaccine has the potential to do more than prevent cases of COVID-19 itself. In the coming years, it could also help doctors treat stubborn forms of cancer.
Researchers at the University of Alabama at Birmingham have identified a new molecular target that could potentially treat the deadly, aging-related lung disease idiopathic pulmonary fibrosis (IPF). The study, which will be published March 10 in the Journal of Experimental Medicine (JEM), suggests that targeting a protein called MDM4 could prevent respiratory failure by initiating a genetic program that removes scar tissue from the lungs.
Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The evidence suggests that activation of this immune cell serves as an early switch that, when activated, drives progressive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD).
Diphtheria - a relatively easily-preventable infection - is evolving to become resistant to a number of classes of antibiotics and in future could lead to vaccine escape, warn an international team of researchers from the UK and India.
In this episode, Dr. Tom Varghese interviews Dr. Sidhu Gangadharan from Beth Israel Deaconess Medical Center and Harvard Medical School.
Administering zinc supplements to covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time. At the same time, it could help to prevent risk groups, like the elderly, from suffering the worst effects of the disease.
In this episode, Dr. David Tom Cooke interviews Dr. Melanie Edwards from Integrated Health Associates in Ypsilanti, Michigan.
In this episode, Dr. Tom Varghese interviews STS Past President Dr. Doug Wood.
Adolescents who vape cannabis are at greater risk for respiratory symptoms indicative of lung injury than teens who smoke cigarettes or marijuana, or vape nicotine, a new University of Michigan study suggests.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, will present four oral and 20 scientific spotlight sessions at the Conference on Retroviruses and Opportunistic Infections (CROI 2021) held virtually, March 6-10.
In this episode, Dr. Tom Varghese interviews Dr. Shanda Blackmon from the Mayo Clinic.
In this episode, Dr. David Tom Cooke interviews Dr. Tom Varghese from the University of Utah. Dr. Varghese shares captivating details of his “very unique life.”
Researchers have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders. This preclinical research paves the way to develop more tailored treatment options for patients with inherited mitochondrial disease and acquired energy disorders.
In this episode, Dr. Tom Varghese interviews Dr. David Tom Cooke from UC Davis Health.
In this episode, Dr. David Tom Cooke interviews STS Director-at-Large Dr. Leah Backhus from Stanford Health Care.
In this episode, Dr. Tom Varghese interviews Dr. Doug Mathisen, STS Historian and Past President.
In this episode, Dr. David Tom Cooke interviews Dr. Joanna Chikwe, chair of the Cardiac Surgery Department in the Smidt Heart Institute at Cedars-Sinai.
A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.
In this episode, Dr. David Tom Cooke interviews Dr. Richard Prager, STS Past President and director of the Frankel Cardiovascular Center at the University of Michigan.
Low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis — an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes — which disproportionately affects African Americans. The discovery by researchers at the University of Illinois Chicago could help guide disease treatment.
In this inaugural episode, Dr. Tom Varghese interviews Dr. Robert Higgins, STS Past President and surgeon-in-chief at The Johns Hopkins Hospital.
Hospitalized patients with COVID-19 and abnormal sodium levels in the blood have an increased risk of experiencing respiratory failure or dying, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Hackensack Meridian Hackensack University Medical Center has become the first hospital in the world to use a new extracorporeal membrane oxygenation (ECMO) system to treat and improve breathing for a patient with COVID-19.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right